Open AccessCOVID-19 Induced Cardiovascular Complications and Recent Therapeutic Advances
Author(s) -
Selia Chowdhury,
Mehedi Hasan Bappy,
Samia Chowdhury,
Md. Shahraj Chowdhury,
Nurjahan Shipa Chowdhury
Publication year - 2021
Publication title -
european journal of medical and health sciences
Language(s) - English
Resource type - Journals
ISSN - 2593-8339
DOI - 10.24018/ejmed.2021.3.6.1099
Subject(s) - covid-19 , medicine , pericardial effusion , pandemic , intensive care medicine , endothelial dysfunction , disease , heart failure , myocarditis , cardiology , infectious disease (medical specialty) , pathology , outbreak
A global pandemic instigated by SARS-CoV-2 virus has been going strongly for almost two years. There have been almost 240 million cases with almost 5 million fatalities all over the world so far. COVID has affected almost every aspect of people’s lives halting the world in immeasurable ways. Although COVID-19 is mostly affecting the respiratory system, it is also responsible for a significant amount of cardiovascular system involvement. On one hand, it deteriorates any pre-existing cardiovascular condition, on another hand, it triggers other inflammation-facilitated acute events. They comprise of inflammatory heart disease, severe pericardial effusion, ventricular arrhythmias, endothelial dysfunction, pulmonary hypertension, heart failure, and many more. In this article, we summarize the features, management, and treatment of several important COVID-19 induced cardiovascular complications. Recent advances in the treatment of these diseases along with the justification and concerns of specific therapeutic measures are also discussed.